A.M. Vitals: FDA Panel Unanimously Recommends Novartis MS Drug

A.M. Vitals: FDA Panel Unanimously Recommends Novartis MS Drug

Shirley S. Wang

Also: price transparency for health-care costs; production woes at drug manufacturing plants; the genetics of autism.

Read more this great post here

No comments yet. Be the first.

Leave a reply

 
Google
Web ekstrapalma.com

RSS Health Care Blog News